Welcome to our dedicated page for Carecloud news (Ticker: CCLD), a resource for investors and traders seeking the latest updates and insights on Carecloud stock.
CareCloud, Inc. reports developments in AI-powered healthcare technology and revenue cycle management for medical practices and health systems. Company updates center on electronic health records, practice management, medical billing, patient experience management, business intelligence, digital health, and AI product portfolios including stratusAI, cirrusAI, and Marketware.
Recurring news themes include quarterly results, guidance, customer selections, product expansion into inpatient EHR, RCM, and analytics, and capital-structure actions involving credit facilities and preferred-stock matters. Updates also address cross-sell strategy, automation initiatives, conference presentations, and operational performance across its Healthcare IT and Medical Practice Management activities.
CareCloud (Nasdaq: CCLD) used its May 19, 2026 Analyst Day to outline four growth themes: an AI-first platform, a simplified common-stock structure, rising free cash flow, and a disciplined acquisition strategy.
The company redeemed all remaining Series B preferred stock on May 15, 2026 using part of a $50 million credit facility, eliminating about $140 million of preferred equity and roughly $13.5 million in annual preferred dividends. Free cash flow has increased about six-fold since 2023, with 2026 guidance of approximately $25 million, and related principal and interest obligations expected to be less than half of that amount.
CareCloud highlighted AI tools such as its Stratus AI Front Desk Agent, which now autonomously handles about three of every four inbound patient calls. Since its 2014 IPO, the company has completed more than 20 tuck-in acquisitions. Customers including Fox Rehabilitation, KabaFusion, and The Lung Center reported improvements in denial rates, bad debt, claim resolution, chart completion, and call scheduling tied to CareCloud’s solutions.
CareCloud (Nasdaq: CCLD) fully redeemed 100% of its 8.75% Series B Preferred Stock, funded by a new $50 million credit facility led by Citizens Bank with Provident Bank participation. The move replaces higher-cost preferred equity with lower-cost debt and simplifies the capital structure.
Since 2015, revenue grew from about $23 million to approximately $130 million expected in 2026, with over 20 acquisitions, more than 45,000 providers served, first full year of positive GAAP net income in 2025, and about $30 million expected 2026 annualized adjusted EBITDA.
CareCloud also maintains a $60 million ATM equity facility and plans to issue shares only at or above $5.00 per share.
CareCloud (Nasdaq: CCLD) will host its 2026 Analyst Day on May 19, 2026, at Nasdaq MarketSite, focusing on capital structure, AI strategy, and growth.
CareCloud closed a $50 million credit facility and prefunded about $41.6 million to fully redeem Series B Preferred Stock on May 15, reducing preferred equity and lowering its cost of capital without common shareholder dilution.
CareCloud (Nasdaq: CCLD) reported Q1 2026 revenue of $31.3M (up 13% YoY) and GAAP net income of $0.922M. Adjusted EBITDA was $5.4M. The company closed a $50M credit facility, announced full redemption of Series B preferred stock (scheduled May 15, 2026), launched AI products, and reaffirmed full-year 2026 guidance of $128–$132M revenue, $29–$31M adjusted EBITDA, and GAAP EPS $0.20–$0.23.
Management cited Medsphere integration costs and elevated amortization as near-term impacts and expects margin expansion later in 2026.
CareCloud (Nasdaq: CCLD) will report first quarter 2026 financial results before market open on May 7, 2026 and host a conference call at 8:30 a.m. ET.
Investors can join via live webcast and download slides at ir.carecloud.com/events. Audio-only dial‑in options and a replay available about three hours after the call.
CareCloud (Nasdaq: CCLD) reaffirmed its previously issued financial guidance after completing a capital structure simplification on April 16, 2026.
Key actions include closing a $50 million credit facility and redeeming 100% of Series B preferred stock. The company reports ~$130 million revenue and ~$30 million annualized adjusted EBITDA, citing improved financial flexibility and institutional support for its next growth phase.
CareCloud (Nasdaq: CCLD, CCLDO) closed a $50 million credit facility on April 13, 2026, with Citizens Bank and Provident Bank and will fully redeem 100% of its outstanding 8.75% Series B preferred stock on May 15, 2026.
The redemption covers 1,511,372 shares at a Total Redemption Price of $27.52 per share, eliminates roughly $3.2 million in annual preferred dividends, and simplifies the capital structure while preserving non-dilutive institutional financing and liquidity.
CareCloud (Nasdaq: CCLD) announced a new partnership with Arkansas Otolaryngology Center to deploy AI-enabled practice management and revenue cycle management (RCM) solutions across the multi-location ENT practice.
The collaboration will deliver AI-powered claims management, automated denial prevention, coding education, real-time dashboards, and AI-driven financial analytics aimed at accelerating revenue capture and improving clean claim rates, with the company emphasizing reductions in days in accounts receivable and enhanced operational transparency.
CareCloud (Nasdaq: CCLD) will present at the 2026 AAPPR Annual Conference in Orlando, April 13–15, showcasing its Marketware physician strategy platform and a soon-to-launch AI update.
Marketware aims to improve pipeline visibility, accelerate time-to-fill, match clinical candidates to best-fit roles, and measure recruitment ROI. The presentation, “The Right Data, Right Now: Recruitment Reporting That Matters,” will highlight real-time pipeline visibility, actionable workforce strategy, and ROI from recruitment investments.
CareCloud (Nasdaq: CCLD) highlighted the completed Preferred A conversion and progress toward simplifying capital structure. The March 6, 2025 conversion issued ~26 million common shares, raising total common shares from ~16 million to ~42 million. The company reaffirmed prior financial guidance and cited recurring revenue and strong cash flow.
CareCloud noted a recent closing price of $3.49 (March 27, 2026) and said ~3 substantial Preferred A holders remain outstanding; ~ $40 million of Series B preferred remains non-convertible.